Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Shimazaki

Showing results (51-60 of 189) with videos related to

Pageof 19
Sort By:
Leukemia|March 10, 2001
Autologous peripheral blood stem cell transplantation for adult patients with B-cell lymphoma-associated hemophagocytic syndromeH Hirai, C Shimazaki, M Hatsuse, et al.
Leukemia Research|January 4, 2001
A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cellsR Takahashi, C Shimazaki, T Inaba, et al.
American Journal of Hematology|March 1, 1994
IgE plasma cell leukemia successfully treated with combination VAD (vincristine, doxorubicin, dexamethasone) and MP (melphalan, prednisolone) followed by interferon-alphaN Yamagata, C Shimazaki, H Goto, et al.
Acta Haematologica|January 1, 1993
Recombinant human granulocyte colony-stimulating factor in combination with continuous infusion of cytosine arabinoside for the treatment of refractory acute myelogenous leukemiaH Goto, C Shimazaki, T Hirata, et al.
Leukemia|April 1, 1995
Establishment of a novel myeloma cell line KPMM2 carrying t(3;14)(q21;q32), which proliferates specifically in response to interleukin-6 through an autocrine mechanismH Goto, C Shimazaki, T Tatsumi, et al.
Bone Marrow Transplantation|April 5, 2005
Successful non-T-cell-depleted HLA-haploidentical stem cell transplantation (SCT) with reduced-intensity conditioning from a second child for late graft failure after the first HLA-haploidentical SCT for MDS/overt leukemia based on feto-maternal microchimerismS Fuchida, S Nakano, N Yamada, et al.
Acta Haematologica|January 1, 1993
Trilineage response in severe aplastic anemia following long-term therapy with recombinant human granulocyte colony-stimulating factorE Ashihara, C Shimazaki, T Hirata, et al.
Bone Marrow Transplantation|September 1, 1993
Autoimmune thrombocytopenia following peripheral blood stem cell autograftingE Ashihara, C Shimazaki, T Hirata, et al.
Leukemia|October 22, 2005
Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host diseaseM Okamoto, A Okano, S Akamatsu, et al.
Acta Haematologica|January 1, 1992
Effects of interleukin-3 and interleukin-6 on peripheral blood cells from multiple myeloma patients and their clinical significanceH Goto, C Shimazaki, E Ashihara, et al.
Pageof 19

Showing results (51-60 of 189) with videos related to

Sort By:
Pageof 19
Leukemia|March 10, 2001
Autologous peripheral blood stem cell transplantation for adult patients with B-cell lymphoma-associated hemophagocytic syndromeH Hirai, C Shimazaki, M Hatsuse, et al.
Leukemia Research|January 4, 2001
A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cellsR Takahashi, C Shimazaki, T Inaba, et al.
American Journal of Hematology|March 1, 1994
IgE plasma cell leukemia successfully treated with combination VAD (vincristine, doxorubicin, dexamethasone) and MP (melphalan, prednisolone) followed by interferon-alphaN Yamagata, C Shimazaki, H Goto, et al.
Acta Haematologica|January 1, 1993
Recombinant human granulocyte colony-stimulating factor in combination with continuous infusion of cytosine arabinoside for the treatment of refractory acute myelogenous leukemiaH Goto, C Shimazaki, T Hirata, et al.
Leukemia|April 1, 1995
Establishment of a novel myeloma cell line KPMM2 carrying t(3;14)(q21;q32), which proliferates specifically in response to interleukin-6 through an autocrine mechanismH Goto, C Shimazaki, T Tatsumi, et al.
Bone Marrow Transplantation|April 5, 2005
Successful non-T-cell-depleted HLA-haploidentical stem cell transplantation (SCT) with reduced-intensity conditioning from a second child for late graft failure after the first HLA-haploidentical SCT for MDS/overt leukemia based on feto-maternal microchimerismS Fuchida, S Nakano, N Yamada, et al.
Acta Haematologica|January 1, 1993
Trilineage response in severe aplastic anemia following long-term therapy with recombinant human granulocyte colony-stimulating factorE Ashihara, C Shimazaki, T Hirata, et al.
Bone Marrow Transplantation|September 1, 1993
Autoimmune thrombocytopenia following peripheral blood stem cell autograftingE Ashihara, C Shimazaki, T Hirata, et al.
Leukemia|October 22, 2005
Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host diseaseM Okamoto, A Okano, S Akamatsu, et al.
Acta Haematologica|January 1, 1992
Effects of interleukin-3 and interleukin-6 on peripheral blood cells from multiple myeloma patients and their clinical significanceH Goto, C Shimazaki, E Ashihara, et al.
Pageof 19